DOC
JAN
TOL
EGP

Katherine M. Sandstrom

Known title: DirectorCIK: 0001748663

Katherine M. Sandstrom's purchase track record

How the stock did after each of Katherine M. Sandstrom's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
3
of 3 since April 28, 2025
Stock higher 6 months later
100%
3 months: 67%
Median 6-month return
+20.0%
3 months: +6.4%
Beat the S&P 500
67%
median +9.8% vs. index
PurchaseStockAmount3 months6 months
3/23/2026JAN$270K+11.5%+27.8%
8/6/2025TOL$9K+6.4%+20.0%
4/28/2025DOC$199K-1.1%+11.1%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

Healthpeak Sets Q3 2026 Earnings Date and Declares Q4 Dividend. Healthpeak Properties announced the dates for its third‑quarter 2026 earnings release, conference call, and webcast. The company also declared a monthly common‑stock cash dividend for the fourth quarter of 2026. These updates give investors a schedule for upcoming earnings and confirm the firm’s continued dividend payments, which can influence trading activity.

this person other insiders at DOC

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 6, 2026

Janus Living Sets Q3 2026 Earnings Date. Janus Living has announced the schedule for its third-quarter 2026 earnings release and conference call. This upcoming event will provide investors with the company's latest financial results and management commentary. The stock is currently trading near its 52-week low, with an average analyst target of $34.71.

this person other insiders at JAN

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

Morgan Stanley initiates Toll Brothers coverage with Overweight rating. Morgan Stanley began covering Toll Brothers with an Overweight rating and a $159 price target. The firm positioned the homebuilder favorably compared to Berkshire Hathaway's preferred peers. This analyst action adds to a broader group of initiations reported this week, providing fresh institutional perspective on the stock.

this person other insiders at TOL

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

Evercore Lowers EastGroup Target to $199 Amid New Directors. Evercore ISI Group kept its rating for EastGroup Properties but lowered its price target to $199. The company also added several new directors to its board. Analysts still view the stock near its 52‑week range, and a comparison with Shoals highlights similar value points.

this person other insiders at EGP

Transaction History

DOC▲ Buy$0
JAN▲ Buy$0
JAN▲ Buy$0
JAN▲ Buy$270K
TOL▲ Buy$0
TOL▲ Buy$9K
EGP▲ Buy$0
DOC▲ Buy$199K
DOC▲ Buy$0
EGP▲ Buy$0
DOC▲ Buy$0
EGP▲ Buy$0
DOC▲ Buy$0
EGP▲ Buy$0
DOC▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.